Drug intelligence / Profile preview

swine Mycoplasma inactivated vaccine

Development stage
Unknown
Lead developer
Zoetis
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Swine Mycoplasma inactivated vaccines are veterinary biologics used to immunize pigs against *Mycoplasma hyopneumoniae*, the primary pathogen responsible for Enzootic Pneumonia and a major contributor to the Porcine Respiratory Disease Complex (PRDC). These vaccines consist of chemically or physically inactivated (killed) whole-cell bacterial cultures. They are typically formulated with adjuvants, such as oil-in-water emulsions, carbomers, or aluminum salts, to stimulate a robust immune response. Vaccination is generally performed in piglets to reduce the severity of lung lesions, decrease bacterial shedding, and improve average daily weight gain. Leading products in this category are developed by major animal health companies including Zoetis, Boehringer Ingelheim, and Merck Animal Health.

Brand names
RespiSureIngelvac MycoFLEXM+PacHyorespPorcilis M HyoSuvaxyn M. hyo
Other names
Mycoplasma hyopneumoniae vaccine, inactivatedM. hyo bacterinswine Mycoplasma vaccine

Beyond the preview

Go deeper on swine Mycoplasma inactivated vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on swine Mycoplasma inactivated vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call